Patents by Inventor Alex VASUTHASAWAT

Alex VASUTHASAWAT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSION PROTEIN COMPOSITION(S) COMPRISING MASKED TYPE I INTERFERONS (IFNA AND IFNB) FOR USE IN THE TREATMENT OF CANCER AND METHODS THEREOF
    Publication number: 20240076316
    Abstract: Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.
    Type: Application
    Filed: September 14, 2023
    Publication date: March 7, 2024
    Applicant: Qwixel Therapeutics LLC
    Inventors: David STOVER, Sherie MORRISON, Alex VASUTHASAWAT, Kham TRINH, George AYOUB
  • Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof
    Patent number: 11795198
    Abstract: Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: October 24, 2023
    Assignee: Qwixel Therapeutics LLC
    Inventors: David Stover, Sherie Morrison, Alex Vasuthasawat, Kham Trinh, George Ayoub
  • FUSION PROTEIN COMPOSITION(S) COMPRISING MASKED TYPE I INTERFERONS (IFNA AND IFNB) FOR USE IN THE TREATMENT OF CANCER AND METHODS THEREOF
    Publication number: 20220056076
    Abstract: Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.
    Type: Application
    Filed: September 2, 2021
    Publication date: February 24, 2022
    Applicant: Qwixel Therapeutics LLC
    Inventors: David STOVER, Sherie MORRISON, Alex VASUTHASAWAT, Kham TRINH, George AYOUB
  • Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof
    Patent number: 11136353
    Abstract: Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: October 5, 2021
    Assignee: Qwixel Therapeutics LLC
    Inventors: David Stover, Sherie Morrison, Alex Vasuthasawat, Kham Trinh, George Ayoub
  • ANTIBODY-INTERFERON FUSION PROTEINS FOR ENHANCING ADOPTIVE T CELL THERAPIES FOR THE TREATMENT OF CANCER
    Publication number: 20210087249
    Abstract: In various embodiments methods are provided that involve the use of antibody-interferon (Ab-IFN) fusion proteins to boost the cancer-fighting capacity of adoptive T cell therapies (ACT), including any T cells that are manipulated and grown outside the body, then returned to the patient with the goal of having the infused T cells home to sites of tumor and destroy the cancer in an immunologic attack. Illustrative, but non-limiting, adoptive T cell therapies include chimeric antigen receptor (CAR) T cells, tumor-infiltrating lymphocytes (TILs), virus-specific T cells, and T cell receptor transgenic T cells.
    Type: Application
    Filed: March 18, 2019
    Publication date: March 25, 2021
    Inventors: John Matthew Timmerman, Reiko King, Patricia Young, Alex Vasuthasawat, Kham M. Trinh, Sherie Leaver Morrison
  • FUSION PROTEIN COMPOSITION(S) COMPRISING MASKED TYPE I INTERFERONS (IFNA AND IFNB) FOR USE IN THE TREATMENT OF CANCER AND METHODS THEREOF
    Publication number: 20200331966
    Abstract: Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.
    Type: Application
    Filed: April 15, 2020
    Publication date: October 22, 2020
    Applicant: Qwixel Therapeutics
    Inventors: David STOVER, Sherie MORRISON, Alex VASUTHASAWAT, Kham TRINH, George AYOUB